3D cell culture market is estimated to be over US$ 600.0 Bn in 2017. It is anticipated to grow at a CAGR of 19.8% from 2019 to 2030. Increasing R&D investments & funding from both private and public sector in the field of cell-based research has presented a bright prospect for the growth of 3D cell culture market. Introduction of innovative new techniques has further led to wide scale application of such techniques and application of 3D cell culture FOR artificially growing biological entities.
Rising prevalence and incidences of several diseases worldwide has triggered the need for advanced R&D scenario across all sectors of biotechnology, life sciences, pharmaceuticals and research establishments. Both public and private sectors are now focusing on new innovative techniques, ideas to obtain latest breakthroughs in the field of life sciences. According to studies, it was estimated that the total spending on R&D by mid-market biotechnology companies, witnessed an increment of approximately 18% between 2015 and 2016. Growing need to address several forms of ailments has been crucial in dictating the funding and R&D spending by governmental establishments as well as major market players and other research institutes. Increasing R&D investments and spending is anticipated to positively contribute to the growth of the global 3D cell culture market.
Major Key Players of the 3D Cell Culture Market are:
Corning, Thermo Fisher Scientific, Merck & Co., Lonza, 3D Biotek, InSphero, REPROCELL USA Inc., Nano3D Biosciences, Inc., SYNTHECON, INCORPORATED and QGel SA, Lausanne, Switzerland.
No comments:
Post a Comment